Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.80 |
| ▸ | CA9 | Q16790 | 2/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9005288 | 0.89 | — | — | |
| SCHEMBL1512953 | 0.89 | — | — | |
| SCHEMBL165 | 0.89 | — | — | |
| SCHEMBL10618143 | 0.80 | — | — | |
| SCHEMBL461657 | 0.80 | — | — | |
| SCHEMBL444194 | 0.80 | — | — | |
| SCHEMBL674048 | 0.80 | — | — | |
| SCHEMBL7885266 | 0.80 | CA1 (0.80) | CA1CA9ALDH1A1TSHRTDP1 | |
| SCHEMBL11418636 | 0.80 | — | — | |
| SCHEMBL1774535 | 0.80 | CA1 (0.80) | CA1CA9ALDH1A1TSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118398321-B | Actinide magnetic ionic liquid and preparation method and application thereof | 北京大学 | 2024-10-15 | — | — | CN | disclosed |
| CN-118398321-A | Actinide magnetic ionic liquid and preparation method and application thereof | 北京大学 | 2024-07-26 | — | — | CN | disclosed |
| CN-118206624-A | ELISA kit suitable for rehabilitation diagnosis of syphilis patient | 南华大学 | 2024-06-18 | — | — | CN | disclosed |
| CN-110554187-B | Expression protein for detecting bovine viral diarrhea virus antibody, ELISA kit, preparation method and application thereof | 内蒙古元山生物科技有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-110554187-A | Expression protein for detecting bovine viral diarrhea virus antibody, ELISA kit, preparation method and application thereof | INNER MONGOLIA YUANSHAN BIOTECHNOLOGY CO LTD | 2019-12-10 | — | — | CN | disclosed |
| US-8481002-B2 | Method of preparation of uranium nitride | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2013-07-09 | — | — | US | disclosed |
| US-20120073956-A1 | METHOD OF PREPARATION OF URANIUM NITRIDE | LOS ALAMOS NATIONAL SECURITY, LLC (US) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120073956-A1 | METHOD OF PREPARATION OF URANIUM NITRIDE | SOD1, UNG, UPP1 | CA1 3631/4885CA9 3166/4885ALDH1A1 1028/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.